Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RF (radiofrequency) ablation promising for head and neck cancers:

This article was originally published in Clinica

Executive Summary

Radiofrequency (RF) ablation therapy could significantly reduce pain and discomfort experienced by patients with advanced tumours in the mouth and throat, according to the first formal study of the technique in patients with head and neck cancer. The study, lead by Randall Owen, of Montefiore Medical Center, in New York, appears in Head & Neck (August 2002). RF ablation controlled the cancer locally, led to minimal damage to healthy surrounding tissue and was palliative, Dr Owen reported. According to the National Cancer Institute, head and neck cancers account for around 3% of all cancers in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067522

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel